Companies
Intralytix
Next-gen biologics — High-efficacy payloads.
- Country
- United States
Coverage
| EU | US | |
|---|---|---|
| livestock-aqua | ✓ | ✓ |
Regulatorsfdaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Capacity | 1,500 L fermenter scale | intralytix.com |
| Certification | Safe Quality Food (SQF) certification, Kosher, Halal, OMRI-listed | intralytix.com |
| Regulatory approval | FDA-cleared and USDA-approved phage products for food safety; FDA IND clearances for clinical trials | intralytix.com |
| Headcount | 31 to 36 employees | zippia.com |
| Revenue | $3.8M to $5.1M annually medium confidence | zippia.com |
Independent sources: zippia.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Microbiome and bacteriophage preparations for animals | livestock-aqua | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.